Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gerber

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
The EMBO Journal|July 2, 2004
VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesisJianying Dong, Jeremy Grunstein, Max Tejada, et al.
The Journal of Biological Chemistry|November 10, 2005
Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGFWei-Ching Liang, Xiumin Wu, Franklin V Peale, et al.
Nanotoxicology|January 15, 2011
Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cellsFabian Blank, Peter Gerber, Barbara Rothen-Rutishauser, et al.
Molecular Cancer Therapeutics|October 22, 2017
Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1)Matthew Sung, Xingzhi Tan, Bingwen Lu, et al.
The Journal of Biological Chemistry|March 6, 2002
ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivoGieri Camenisch, Maria Teresa Pisabarro, Daniel Sherman, et al.
Mabs|January 13, 2010
Anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemiaMay Kung Sutherland, Changpu Yu, Timothy S Lewis, et al.
Cell|March 12, 2003
HIF-1alpha is essential for myeloid cell-mediated inflammationThorsten Cramer, Yuji Yamanishi, Björn E Clausen, et al.
Plos One|July 21, 2017
Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patientsSteven R Pirie-Shepherd, Cory Painter, Pamela Whalen, et al.
Molecular Cancer Therapeutics|September 16, 2008
Engineered anti-CD70 antibody-drug conjugate with increased therapeutic indexCharlotte F McDonagh, Kristine M Kim, Eileen Turcott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
Liver Microvascular Injury and Thrombocytopenia of Antibody-Calicheamicin Conjugates in Cynomolgus Monkeys-Mechanism and MonitoringMagali Guffroy, Hadi Falahatpisheh, Kathleen Biddle, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
The EMBO Journal|July 2, 2004
VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesisJianying Dong, Jeremy Grunstein, Max Tejada, et al.
The Journal of Biological Chemistry|November 10, 2005
Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGFWei-Ching Liang, Xiumin Wu, Franklin V Peale, et al.
Nanotoxicology|January 15, 2011
Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cellsFabian Blank, Peter Gerber, Barbara Rothen-Rutishauser, et al.
Molecular Cancer Therapeutics|October 22, 2017
Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1)Matthew Sung, Xingzhi Tan, Bingwen Lu, et al.
The Journal of Biological Chemistry|March 6, 2002
ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivoGieri Camenisch, Maria Teresa Pisabarro, Daniel Sherman, et al.
Mabs|January 13, 2010
Anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemiaMay Kung Sutherland, Changpu Yu, Timothy S Lewis, et al.
Cell|March 12, 2003
HIF-1alpha is essential for myeloid cell-mediated inflammationThorsten Cramer, Yuji Yamanishi, Björn E Clausen, et al.
Plos One|July 21, 2017
Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patientsSteven R Pirie-Shepherd, Cory Painter, Pamela Whalen, et al.
Molecular Cancer Therapeutics|September 16, 2008
Engineered anti-CD70 antibody-drug conjugate with increased therapeutic indexCharlotte F McDonagh, Kristine M Kim, Eileen Turcott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
Liver Microvascular Injury and Thrombocytopenia of Antibody-Calicheamicin Conjugates in Cynomolgus Monkeys-Mechanism and MonitoringMagali Guffroy, Hadi Falahatpisheh, Kathleen Biddle, et al.
Pageof 11